Skip to main content
SpringerLink
Log in

Excessive Daytime Somnolence Associated with Parkinson’s Disease

  • Chapter
Disorders of Sleep and Circadian Rhythms in Parkinson's Disease

  • 1179 Accesses

Abstract

Excessive daytime sleepiness (EDS) occurs in up to 50 % of patients with Parkinson’s disease (PD) and is characterized by an inability to maintain full alertness in the daytime and undesirable lapses into sleep. Often overshadowed by the motor symptoms of PD, EDS can contribute to home and automobile accidents and have a negative impact on mood and overall quality of life. Sleep disturbances and EDS can result from the medications used to treat PD, degeneration of neuronal systems involved in the control of the sleep–wake system that occurs as part of the PD disease process, and comorbid conditions including specific sleep disorders and depression. The treatment of EDS in the PD patient requires careful evaluation of the multiple contributing causes and instituting recommendations that can consist of sleep hygiene and behavioral changes, alterations in the dosing and timing of PD medications, treatment of comorbid disorders, and the use of medications that affect nocturnal sleep quality and daytime alertness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ghorayeb I, Loundou A, Auquier P, et al. A nationwide survey of excessive daytime sleepiness in Parkinson’s disease in France. Mov Disord. 2007;22:1567–72.

    Article  PubMed  Google Scholar 

  2. Breen DP, Williams-Gray CH, Mason SL, et al. Excessive daytime sleepiness and its risk factors in incident Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2013;84:233–4.

    Article  PubMed  Google Scholar 

  3. Boddy F, Rowan EN, Lett D, et al. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson’s disease with and without dementia, dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22:529–35.

    Article  PubMed  Google Scholar 

  4. Ondo WG, Dat Vuong K, Khan H, et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology. 2001;57:1392–6.

    Article  CAS  PubMed  Google Scholar 

  5. Arnulf I, Leu-Semenescu S. Sleepiness in Parkinson’s disease. Parkinsonism Relat Disord. 2009;15 Suppl 3:S101–4.

    Article  PubMed  Google Scholar 

  6. Manni R, Terzaghi M, Sartori I, et al. Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Sleep Med. 2003;5:189–93.

    Article  Google Scholar 

  7. Rissling I, Körner K, Geller F, et al. Preprohypocretin polymorphism in Parkinson’s disease patients reporting “sleep attacks”. Sleep. 2005;28:871–5.

    PubMed  Google Scholar 

  8. Meindorfner C, Korner Y, Moller JC, et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord. 2005;20:832–42.

    Article  PubMed  Google Scholar 

  9. Uc EY, Rizzo M, Anderson SW, et al. Driving with distraction in Parkinson’s disease. Neurology. 2006;67:1774–80.

    Article  CAS  PubMed  Google Scholar 

  10. Brunner H, Wetter TC, Hogl B, et al. Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson’s disease: effects of dopaminergic treatment. Mov Disord. 2002;17:928–33.

    Article  PubMed  Google Scholar 

  11. Friedman A. Sleep pattern in Parkinson’s disease. Acta Med Pol. 1980;21:193–9.

    CAS  PubMed  Google Scholar 

  12. Scaglione C, Vignatelli L, Plazzi G, et al. REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based study. Neurol Sci. 2005;25:316–21.

    Article  CAS  PubMed  Google Scholar 

  13. Wetter TC, Trenkwalder C, Gershanik O, et al. Polysomnographic measures in Parkinson’s disease: a comparison between patients with and without REM sleep disturbances. Wien Klin Wochenschr. 2001;113:249–53.

    CAS  PubMed  Google Scholar 

  14. Shpirer I, Minovitz A, Klein C, et al. Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study. Mov Disord. 2006;21:1432–8.

    Article  PubMed  Google Scholar 

  15. Rye D, Bliwise DL, Dihenia B, et al. Daytime sleepiness in Parkinson’s disease. J Sleep Res. 2000;9:63–9.

    Article  CAS  PubMed  Google Scholar 

  16. Nass A, Nass RD. Actigraphic evidence for night-time hyperkinesias in Parkinson’s disease. Int J Neurosci. 2008;118:291–310.

    Article  PubMed  Google Scholar 

  17. Amara A, Ray R, Walker H. The effects of deep brain stimulation on sleep in Parkinson’s disease. Ther Adv Neurol Disord. 2011;4(1):15–24.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson’s disease. Brain. 2007;130:1577–85.

    Article  PubMed  Google Scholar 

  19. Wienecke M, Werth E, Poryazove R, et al. Progressive dopamine and hypocretin deficiencies in Parkinson’s disease: is there an impact on sleep and wakefulness? J Sleep Res. 2012;21:710–7.

    Article  PubMed  Google Scholar 

  20. Yasui K, Inoue Y, Kanbayashi T, et al. CSF orexin levels in Parkinson’s disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci. 2006;250:120–3.

    Article  CAS  PubMed  Google Scholar 

  21. Zoltoski RK, Velazquez-Moctezuma J, Shiromani PJ, et al. The relative effects of selective M1 muscarinic antagonists on rapid eye movement sleep. Brain Res. 1993;608:186–90.

    Article  CAS  PubMed  Google Scholar 

  22. Garcia-Borreguero D, Caminero AB, de la Llave Y, et al. Decreased phasic EMG activity during rapid eye movement sleep in treatment of naive Parkinson’s disease: effects of treatment with levodopa and progression of illness. Mov Disord. 2002;17:934–41.

    Article  PubMed  Google Scholar 

  23. Rye DB. Parkinson’s disease and RLS: the dopaminergic bridge. Sleep Med. 2004;5:317–28.

    Article  PubMed  Google Scholar 

  24. Gjerstad MD, Alves G, Wentzel-Larsen T, et al. Excessive daytime sleepiness in Parkinson’s disease: is it the drugs or the disease? Neurology. 2006;6:853–8.

    Article  Google Scholar 

  25. Kaynak D, Kiziltan G, Kaynak H, et al. Sleep and sleepiness in patients with Parkinson’s disease before and after dopaminergic treatment. Eur J Neurol. 2005;12:199–207.

    Article  CAS  PubMed  Google Scholar 

  26. Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson’s disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol. 2004;61:97–102.

    Article  PubMed  Google Scholar 

  27. Ghys L, Surmann E, Whitesides J, et al. Effect of rotigotine on sleep and quality of life in Parkinson’s disease patients: post hoc analysis of RECOVER patient who were symptomatic at baseline. Expert Opin Pharmacother. 2011;12(13):1985–98.

    Article  CAS  PubMed  Google Scholar 

  28. Trenkwalder C, Kies B, Rudzinska M, et al., Recover Study Group. Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebocontrolled study (RECOVER). Mov Disord. 2011;26(1):90–9.

    Google Scholar 

  29. Kurth MC, Adler CH, Hilaire MS, et al. Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson’s disease experiencing motor fl uctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I. Neurology. 1997;48:81–7.

    Article  CAS  PubMed  Google Scholar 

  30. Hublin C, Partinen M, Heinonen EH, et al. Selegiline in the treatment of narcolepsy. Neurology. 1994;44:2095–101.

    Article  CAS  PubMed  Google Scholar 

  31. Hoy S, Keating G. Rasagiline: a review of its use in the treatment of idiopathic Parkinson’s disease. Drugs. 2012;72(5):643–69.

    Article  PubMed  Google Scholar 

  32. Peppe A, Pierantozzi M, Alamonte V, et al. Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson’s disease patients: one-year follow-up. Sleep. 2012;35(12):1637–42.

    PubMed Central  PubMed  Google Scholar 

  33. Braga-Neto P, da Silva-Junior FP, Sueli Monte F, et al. Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci. 2004;217:41–5.

    Article  PubMed  Google Scholar 

  34. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson’s disease and sleepiness; an integral part of PD. Neurology. 2002;58:1019–24.

    Article  CAS  PubMed  Google Scholar 

  35. Steffen A, Hagenah J, Graefe H, et al. Obstructive sleep apnea in patients with Parkinson’s disease – report of two cases and review. Laryngorhinootologie. 2008;87:107–11.

    Article  CAS  PubMed  Google Scholar 

  36. Gjerstad MD, Wentzel-Larsen T, Aarsland D, et al. Insomnia in Parkinson’s disease: frequency and progression over time. J Neurol Neurosurg Psychiatry. 2007;78:476–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Nomura T, Inoue Y, Miyake M, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord. 2006;21:380–4.

    Article  PubMed  Google Scholar 

  38. Happe S, Pirker W, Kloch G, et al. Periodic leg movements in patients with Parkinson’s disease are associated with reduced striatal dopamine transporter binding. J Neurol. 2003;250:83–6.

    Article  PubMed  Google Scholar 

  39. Postuma RB, Bertand JA, Montplaisir J. Rapid eye movements sleep behavior disorder and risk of dementia in Parkinson’s disease: a prospective study. Mov Disord. 2012;27:720–6.

    Article  PubMed  Google Scholar 

  40. Shulman LM, Taback RL, Rabinstein AA, et al. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2002;8:193–7.

    Article  CAS  PubMed  Google Scholar 

  41. Barnes J, Connelly V, Wiggs L, et al. Sleep patterns in Parkinson’s disease patients with visual hallucinations. Int J Neurosci. 2010;120(8):564–9.

    Article  PubMed  Google Scholar 

  42. Rye D. Excessive daytime sleepiness and Unintended sleep in parkinson’s disease. Curr Neurol Neurosci Rep. 2006;6:169–76.

    Article  PubMed  Google Scholar 

  43. Fernandez HH, Trieschmann ME, Burke MA, et al. Long-term outcome of quetiapine use for psychosis among parkinsonian patients. Mov Disord. 2003;18:510–4.

    Article  PubMed  Google Scholar 

  44. Lokk J. Daytime sleepiness in elderly PD patients and treatment with the psychostimulant modafinil: a preliminary study. Neuropsychiatr Dis Treat. 2010;6:93–7.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Ondo WG, Fayle R, Atassi F, et al. Modafi nil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled prallel trial. J Neurol Neruosurg Psychiatry. 2005;76:1636–9.

    Article  CAS  Google Scholar 

  46. Yang H, Petrini M. Effect of cognitive behavior therapy on sleep disorder in Parkinson’s disease in China: a pilot study. Nurs Health Sci. 2012;14(4):458–63.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Montefiore Medical Center, 111 E. 210th St, Bronx, NY, 10467, USA

    James Battista MD, Renee Monderer MD & Michael Thorpy MD

Authors
  1. James Battista MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renee Monderer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Thorpy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renee Monderer MD .

Editor information

Editors and Affiliations

  1. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Aleksandar Videnovic

  2. Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria

    Birgit Högl

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Wien

About this chapter

Cite this chapter

Battista, J., Monderer, R., Thorpy, M. (2015). Excessive Daytime Somnolence Associated with Parkinson’s Disease. In: Videnovic, A., Högl, B. (eds) Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1631-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1631-9_8

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1630-2

  • Online ISBN: 978-3-7091-1631-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation